New favipiravir derivative is a potent SARS-CoV-2 inhibitor
The search for potent drug inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been underway since the beginning
Read moreThe search for potent drug inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been underway since the beginning
Read moreResearch led by Michael J. Hannon from the University of Birmingham, UK, finds metallo-supramolecular helicates (cylinders) binding to untranslated regions
Read moreSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date,
Read moreWith over 108 million reported infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, and nearly 2.4 million deaths,
Read more